These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35213541)

  • 21. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of the COVID-19 epidemic in the post-vaccination period in Korea: a rapid assessment.
    Min KD; Tak S
    Epidemiol Health; 2021; 43():e2021040. PubMed ID: 34082498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with COVID-19 vaccination in young children.
    Li X; Keown-Stoneman CDG; Anderson LN; Allan K; Fallon BA; Parsons JA; Birken CS; Maguire JL;
    Can J Public Health; 2024 Feb; 115(1):40-52. PubMed ID: 37796366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prioritizing COVID-19 vaccination. Part 2: Real-time comparison between single-dose and double-dose in Japan.
    Kobayashi T; Nishiura H
    Math Biosci Eng; 2022 May; 19(7):7410-7424. PubMed ID: 35730313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of prioritisation and dosing intervals on the effects of COVID-19 vaccination in Europe: an agent-based cohort model.
    Català M; Li X; Prats C; Prieto-Alhambra D
    Sci Rep; 2021 Sep; 11(1):18812. PubMed ID: 34552139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The case for reactive mass oral cholera vaccinations.
    Reyburn R; Deen JL; Grais RF; Bhattacharya SK; Sur D; Lopez AL; Jiddawi MS; Clemens JD; von Seidlein L
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e952. PubMed ID: 21283614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Annual immunisation coverage report 2021.
    Hull B; Hendry A; Dey A; Brotherton J; Macartney K; Beard F
    Commun Dis Intell (2018); 2023 Aug; 47():. PubMed ID: 37817316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact.
    Swan DA; Bracis C; Janes H; Moore M; Matrajt L; Reeves DB; Burns E; Donnell D; Cohen MS; Schiffer JT; Dimitrov D
    Sci Rep; 2021 Jul; 11(1):15531. PubMed ID: 34330945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A scenario modelling analysis to anticipate the impact of COVID-19 vaccination in adolescents and children on disease outcomes in the Netherlands, summer 2021.
    Ainslie KEC; Backer JA; de Boer PT; van Hoek AJ; Klinkenberg D; Korthals Altes H; Leung KY; de Melker H; Miura F; Wallinga J
    Euro Surveill; 2022 Nov; 27(44):. PubMed ID: 36330824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study.
    Diarra M; Kebir A; Talla C; Barry A; Faye J; Louati D; Opatowski L; Diop M; ; White LJ; Loucoubar C; Miled SB
    BMJ Glob Health; 2022 Feb; 7(2):. PubMed ID: 35193893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 vaccination hesitancy and challenges to mass vaccination.
    Chau CYC
    Hong Kong Med J; 2021 Oct; 27(5):377-379. PubMed ID: 34657836
    [No Abstract]   [Full Text] [Related]  

  • 32. The Impact of Priority Settings at the Start of COVID-19 Mass Vaccination on Subsequent Vaccine Uptake in Japan: One-Year Prospective Cohort Study.
    Hori D; Takahashi T; Ozaki A; Tabuchi T
    JMIR Public Health Surveill; 2023 Jul; 9():e42143. PubMed ID: 37235691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal vaccination at high reproductive numbers: sharp transitions and counterintuitive allocations.
    Gavish N; Katriel G
    Proc Biol Sci; 2022 Sep; 289(1983):20221525. PubMed ID: 36168762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An agent-based model to assess large-scale COVID-19 vaccination campaigns for the Italian territory: The case study of Lombardy region.
    Cattaneo A; Vitali A; Mazzoleni M; Previdi F
    Comput Methods Programs Biomed; 2022 Sep; 224():107029. PubMed ID: 35908330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disparities in child and adolescent COVID-19 vaccination coverage and parental intent toward vaccinations for their children and adolescents.
    Nguyen KH; Levisohn A; McChesney C; Vasudevan L; Bednarczyk RA; Corlin L
    Ann Med; 2023 Dec; 55(1):2232818. PubMed ID: 37449878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 Adult, Childhood, and Adolescent Vaccination Coverage Among Military and Civilian Families, United States.
    Nguyen KH; Mansfield KA; Xie CY; Corlin L; Niska RW
    Mil Med; 2023 Jul; 188(7-8):e2651-e2660. PubMed ID: 36695337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 epidemic in New York City: development of an age group-specific mathematical model to predict the outcome of various vaccination strategies.
    Li M; Zu J; Zhang Y; Ma L; Shen M; Li Z; Ji F
    Virol J; 2022 Mar; 19(1):43. PubMed ID: 35292054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better?
    Frenkel LD
    Allergy Asthma Proc; 2021 Sep; 42(5):378-385. PubMed ID: 34474707
    [No Abstract]   [Full Text] [Related]  

  • 40. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.
    Moore S; Hill EM; Tildesley MJ; Dyson L; Keeling MJ
    Lancet Infect Dis; 2021 Jun; 21(6):793-802. PubMed ID: 33743847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.